Page 173 - Orange Book Cumulative Supplement 10 October 2012
P. 173

A - 36
                 PATENT & EXCLUSIVITY DRUG PRODUCT        LIST    -   CUMULATIVE SUPPLEMENT  10  - October 2012
                                          See List footnote   for information regarding List content

                                                PATENT                     PATENT                   EXCLUSIVITY
                                              EXPIRATION      PATENT       DELIST    EXCLUSIVITY    EXPIRATION
               APPL/PROD                         DATE                    REQUESTED                     DATE
                   NO         PATENT NO                       CODES                    CODE(S)
             PALIPERIDONE PALMITATE - INVEGA SUSTENNA
               N022264 004   >A>   5254556   Oct  15, 2013  DS DP U-543                  M-119     Aug  29, 2015
                           >A>   5254556*PED  Apr  15, 2014
             PALIPERIDONE PALMITATE - INVEGA SUSTENNA
               N022264 005   >A>   5254556   Oct  15, 2013  DS DP U-543                  M-119     Aug  29, 2015
                           >A>   5254556*PED  Apr  15, 2014
             PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - CREON
               N020725 004                                                               I-625     Apr  30, 2013
                                                                                         M-93      Jul  29, 2019
                                                                                         NCE       Apr  30, 2014
             PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PERTZYE
               N022175 001                                                               NCE       May  17, 2017
             PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PERTZYE
               N022175 002                                                               NCE       May  17, 2017
             PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ULTRESA
               N022222 001                                                               NCE       Mar  01, 2017
             PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ULTRESA
               N022222 002                                                               NCE       Mar  01, 2017
             PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ULTRESA
               N022222 003                                                               NCE       Mar  01, 2017
             PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - VIOKACE
               N022542 001                                                               NCE       Mar  01, 2017
             PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - VIOKACE
               N022542 002                                                               NCE       Mar  01, 2017
             PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP
               N022210 001     8221747      Feb  20, 2028     DP
                               8246950      Feb  20, 2028        U-1274
             PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP
               N022210 002     8221747      Feb  20, 2028     DP
                               8246950      Feb  20, 2028        U-1274
             PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP
               N022210 003     8221747      Feb  20, 2028     DP
                               8246950      Feb  20, 2028        U-1274
             PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP
               N022210 004     8221747      Feb  20, 2028     DP
                               8246950      Feb  20, 2028        U-1274
             PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP
               N022210 005     8221747      Feb  20, 2028     DP                         NCE       Aug  27, 2014
             PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP
               N022210 006     8221747      Feb  20, 2028     DP                         NCE       Aug  27, 2014

             PAZOPANIB HYDROCHLORIDE - VOTRIENT
               N022465 001     8114885      Dec  19, 2021   DS DP                        I-649     Apr  26, 2015
                                                                                         ODE       Apr  26, 2019
             PAZOPANIB HYDROCHLORIDE - VOTRIENT
               N022465 002     8114885      Dec  19, 2021   DS DP                        I-649     Apr  26, 2015
                                                                                         ODE       Apr  26, 2019
   168   169   170   171   172   173   174   175   176   177   178